V10XX02 ibritumomab tiuxetan (90Y)
ATC group of level 5 – chemical substance · in plain English: radioactive medicines for treatment
This site has the patient leaflet or the SPC of 1 medicine in this group.
- 1 no longer supplied or not available
Active substance: Ibritumomab tiuxetan – all medicines with this substance, also in combinations.
Place in the ATC classification
- V Various drug classes 338 medicines
- V10 Therapeutic radiopharmaceuticals 12 medicines
- V10X Other therapeutic radiopharmaceuticals 9 medicines
- V10XX Various therapeutic radiopharmaceuticals 4 medicines
- V10XX02 ibritumomab tiuxetan (90Y) 1 medicine
- V10XX Various therapeutic radiopharmaceuticals 4 medicines
- V10X Other therapeutic radiopharmaceuticals 9 medicines
- V10 Therapeutic radiopharmaceuticals 12 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Zevalin SPC no longer supplied | – |
Other groups of the same level
- V10XX03 radium (223Ra) dichloride 1 medicine
- V10XX04 lutetium (177Lu) oxodotreotide 2 medicines
Other names of the ATC group
- French: V10XX02 yttrium-90 ibritumomab tiuxétan
- German: V10XX02 (90Y)Ibritumomabtiuxetan
- German: V10XX02 (90Y)Ibritumomabtiuxetan
- Italian: V10XX02 IBRITUMOMAB TIUXETANO (90Y)
- Polish: V10XX02 IBRITUMOMAB-TIUXETAN- [90Y]
- Turkish: V10XX02 ibritumomab tiuxetan (90Y)
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group V10XX02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.